Rogeneous labeling of cancer tissue with no fluorescence detected in the
Rogeneous labeling of cancer tissue with no fluorescence detected in the normalProbes for selective tumor cell deliveryThe availability of FDA-approved therapeutic antibodies, such as cetuximab and trastuzumab have deemed them…